ITEL
23.2.2024 18:36:34 CET | Business Wire | Press release
itel, the global leading smart life brand committed to providing affordable and good quality consumer electronic products, is poised to redefine its visual identity with the spectacular launch of its new logo at the iconic Great Pyramids of Giza in Egypt on February 22. This momentous occasion will not only mark a significant evolution in itel’s brand image but also serve as a platform to engage and celebrate with esteemed partners and customers worldwide, especially customers from the Middle East and North Africa region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222762808/en/
itel successfully launched its 2024 brand launch event at Egyptian Pyramids (Photo: Business Wire)
The unveiling ceremony at the Egyptian Pyramids signifies itel’s commitment not only to technological innovation but also to creating a memorable and immersive experience for attendees. The event will kick off with a breathtaking display of opening fireworks, setting the stage for an evening of celebration and anticipation, followed by an inspiring opening speech. Subsequently, attendees will be treated to a captivating logo Show, where the new logo design will be unveiled with a profound interpretation of its significance to itel’s brand identity.
As part of the event, itel will officially launch the highly anticipated itel P55 series smartphones, including P55+, P55, and P55 5G. These smartphones boast three major technological upgrades: 45W PowerCharge technology with three-gear smart charging; iBoost game space, optimizing the gaming experience. And itel’s first 5G smartphone P55 5G, providing a fast browsing experience for entry-level 5G network customers in emerging markets.
In addition to the smartphone launch, itel also introduced a range of smart life accessories, including smartwatch E1, with features such as blood oxygen monitoring, heartbeat tracking, and health management, intelligent earbuds BudsAce, featuring noise reduction and superior sound quality, and other reliable and affordable home appliances and innovative kids electronics, as part of its commitment to a holistic smart lifestyle.
“We are thrilled to welcome esteemed partners, prominent media representatives, and KOLs to our grand unveiling at the Egyptian Pyramids,” said Steven Yang, North Africa Regional Director of itel. “This event is not merely a product launch. It's an opportunity for friendly exchanges, fostering close customer relationships, promoting future collaborations, and maintaining long-term, close contact with our valued partners. We aim to demonstrate the unparalleled service level of itel’s international brand and showcase our commitment to creating lasting connections in this vibrant and dynamic region.”
The gathering at the Egyptian Pyramids, one of the Eight Wonders of the World, symbolizes itel's transition into a daring new era characterized by innovation and enduring style. Be prepared to witness the unfolding of a new chapter in the brand’s legacy, marking its unwavering commitment to delivering not just technology but a refined and immersive experience.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222762808/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom